OnStream Login

Contact Us

Pharmaceuticals & Life Sciences Blogs - VWV

Pharma & Life Sciences

Articles & Blogs Pharma & Life Sciences

Windsor Framework - The Start of a Brighter EU-UK Life Sciences Future?

Wednesday, 01 March 2023

It would be safe to say that relations between the UK and EU have not been as positive as they could have been since 23 June 2016. This has been particularly felt in pharma and life sciences. Now, with the Windsor Framework, are things going to change?

Windsor Framework - The Start of a Brighter EU-UK Life Sciences Future?

Articles & Blogs Pharma & Life Sciences

Collaboration - Being Prepared and Avoiding the Pitfalls

Thursday, 16 February 2023

This article summarises some key observations from a legal perspective which, based on our experience, we would recommend are considered carefully before launching into any collaborative arrangement.

Collaboration - Being Prepared and Avoiding the Pitfalls

Articles & Blogs Pharma & Life Sciences

UK Pharma Pricing in Crisis

Thursday, 16 February 2023

The UK pharma pricing scheme - the Voluntary Scheme for Branded Medicines Pricing and Access (known as VPAS) is in crisis, and it must change in the new pricing deal from 2024 onwards in order for the UK to be an attractive place for life sciences.

UK Pharma Pricing In Crisis

Articles & Blogs Pharma & Life Sciences

NHS Require Suppliers to Have Carbon Reduction Plan from April 2023

Thursday, 16 February 2023

NHS suppliers will have to start showing their carbon reduction plan from April 2023 for their UK scope 1 and 2 emissions and some scope emissions. This will initially apply to contracts above £5m per year, but will extend to all contracts by April 2024.

NHS Require Suppliers to Have Carbon Reduction Plan from April 2023

Articles & Blogs Pharma & Life Sciences

Duty of Good Faith Will Not Be Implied to Restrict Termination Rights

Thursday, 16 February 2023

In recent years, a duty of good faith has been an evolving area of English law. In a recent case, the High Court has kept that concept in check and would not allow it to affect the interpretation from other express words in an agreement.

Duty of Good Faith Will Not Be Implied to Restrict Termination Rights

Articles & Blogs Pharma & Life Sciences

Steps Forward for CAR T-Cell Therapy Treatments

Thursday, 16 February 2023

CAR-T therapy is to be offered to a wider range of cancer patients in trials, following recent developments in the technology.

Steps Forward for CAR T-Cell Therapy Treatments

Articles & Blogs Pharma & Life Sciences

BioNTech Commit to UK Life Science Sector in New Partnership

Thursday, 19 January 2023

The UK Government has entered into a Memorandum of Understanding (MoU) with BioNTech for the development and trialling of cancer immunotherapies, in a great boost to the UK's Life Sciences credentials.

BioNTech Commit to UK Life Science Sector in New Partnership

Articles & Blogs Pharma & Life Sciences

UK Announces Major Science Co-operation Agreement with Switzerland

Monday, 23 January 2023

The UK and Swiss Governments have signed a major co-operation agreement that will deepen the relations between their countries' research and innovation communities.

UK Announces Major Science Co-Operation Agreement with Switzerland

Articles & Blogs Pharma & Life Sciences

Duty of Good Faith Will Not Be Implied to Restrict Termination Rights

Thursday, 19 January 2023

In recent years, a duty of good faith has been an evolving area of English law. In the recent case of Optimares SpA v Qatar Airways Group, the High Court has kept that concept in check when one party wanted to exercise a contractual right to terminate.

Duty of Good Faith Will Not Be Implied to Restrict Termination Rights

Articles & Blogs Pharma & Life Sciences

GSK Global Headquarters to Move into London's Knowledge Quarter

Monday, 23 January 2023

GSK has announced its plans to relocate to the centre of London in 2024, from its current offices in Brentford.

GSK Global Headquarters to Move into London's Knowledge Quarter

Articles & Blogs Pharma & Life Sciences

Genome UK - England's 2022 to 2025 Implementation Plan Published

Monday, 23 January 2023

Genome UK is a 10 year strategy that lays out the Government's strategy to place the UK as the world leader in genomic healthcare.

Genome UK - England's 2022 to 2025 Implementation Plan Published

Articles & Blogs Pharma & Life Sciences

Two Big Pharma Companies Leave NHS Pricing Scheme Over Punitive VPAS Rebates

Tuesday, 17 January 2023

AbbVie and Eli Lilly have pulled out of the NHS's Voluntary Scheme for Branded Medicines Pricing and Access (known as VPAS). The Association of the British Pharmaceutical Industry (ABPI) has called the rebates under VPAS 'punitive'.

Two Big Pharma Companies Leave NHS Pricing Scheme Over Punitive VPAS Rebates

Articles & Blogs Pharma & Life Sciences

Pioneering Trial on Lab Grown Red Blood Cells Has Promising First Signs

Wednesday, 14 December 2022

In a first of its kind clinical trial, red blood cells grown in a laboratory have been transfused into another human being.

Pioneering Trial on Lab Grown Red Blood Cells Has Promising First Signs

Articles & Blogs Pharma & Life Sciences

Bill to Expedite Innovative Life Sciences Technology for Precision Breeding Progresses

Wednesday, 14 December 2022

A new law is progressing through Parliament, designed to enhance the UK's position with cutting edge life sciences technology opportunities for plant and animal breeding.

Bill to Expedite Innovative Life Sciences Technology for Precision Breeding Progresses

Articles & Blogs Pharma & Life Sciences

Court Applies Words in Royalty Audit Clause Not Another Common Sense Interpretation

Wednesday, 14 December 2022

The wording in commercial contracts can sometimes be disputed, particularly if it is not clearly drafted. An audit clause in a royalty agreement can be pored over when the parties are in dispute and the contract is pulled out of the drawer.

Court Applies Words in Royalty Audit Clause Not Another Common Sense Interpretation

« ‹ 1 2 3 4 5 6 7 8 9 › »